8.49MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00654J1079
CUSIP
00654J107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.01
Dividend Share
-
Dividend Yield
-
Earnings Share
-21.18
Wall Street Target Price
30.00
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
863,232
Gross Profit TTM
-6,108,754
EBITDA
-11,070,066
Profit Margin
500.17%
Return On Assets TTM
-61.71%
Return On Equity TTM
-126.29%
Revenue Per Share TTM
1.2
Qtly Revenue Growth YOY
-81.80%
Diluted Eps TTM
-21.18
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
9.3351
Price Book MRQ
0.6745
Enterprise Value Revenue
7
Enterprise Value EBITDA
0
697.10
4.66%484.79
3.07%95.67
0.12%697.42
0.00%161.37
0.00%116.01
-3.24%190.00
-2.69%270.91
-1.34%650.81
-1.01%85.51
-0.18%